LORI FRIED: Open Payments
NPI 1346804630 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 19 payments from 11 companies in 2025. Trend: 2023 $82 · 2024 $394 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 2 | $230 |
| Gilead Sciences, Inc. | 5 | $106 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Exact Sciences Corporation | 2 | $36 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Lundbeck LLC | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| SANOFI-AVENTIS U.S. LLC | 1 | $14 |
Products named: PIFELTRO, INGREZZA, Cologuard Collection Kit, TRELEGY ELLIPTA, CAPLYTA, REXULTI, FANAPT, TZIELD.
Industry payments across TX — which companies pay providers there.
